M

Milestone Pharmaceuticals
D

MIST

1.50000
USD
-0.13
(-7.69%)
مغلق
حجم التداول
26,153
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
179,456,087
المقالات
المزيد

العنوان: Milestone Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.